LISATA THERAPEUTICS, INC. — Director's Dealing 2014

Nov 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-11-24

Reporting Person: Pecora Andrew L (Director, Chief Visionary Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-24	Common Stock, $0.001 par value	P	12500	$4.012	Acquired	343220	Direct